BMO Capital on Acadia Pharmaceuticals (ACAD): 'IP Protection Pushes Target to $28'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 20.59 -0.17 (0.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $20.76 | 52 Week High | $42.49 | |||
| Open | $20.88 | 52 Week Low | $16.64 | |||
| Day High | $21.01 | P/E | N/A | |||
| Day Low | $20.49 | EPS | $-0.42 | |||
| Volume | 1,137,498 | |||||
